Name: | Cefoxitin |
---|---|
PubChem Compound ID: | 2638 |
Description: | A semisynthetic cephamycin antibiotic resistant to beta-lactamase. |
Molecular formula: | C16H17N3O7S2 |
Molecular weight: | 427.454 g/mol |
Name: | Cefoxitin |
---|---|
Name (isomeric): | DB01331 |
Drug Type: | small molecule |
Description: | A semisynthetic cephamycin antibiotic resistant to beta-lactamase. |
Brand: | Mefoxitin, Mefoxin |
Category: | Cephalosporins, Anti-Bacterial Agents, Antibacterial Agents |
CAS number: | 35607-66-0 |
Indication: | For the treatment of serious infections caused by susceptible strains microorganisms. |
---|---|
Pharmacology: |
Cefoxitin is a cephamycin antibiotic often grouped with the second-generation cephalosporins. It is active against a broad range of gram-negative bacteria including anaerobes. The methoxy group in the 7a position provides cefoxitin with a high degree of stability in the presence of beta-lactamases, both penicillinases and cephalosporinases, of gram...
show more » |
Mechanism of Action: | The bactericidal action of cefoxitin results from inhibition of cell wall synthesis. |
Biotransformation: | Minimal (approximately 85 percent of cefoxitin is excreted unchanged by the kidneys over a 6-hour period). |
Route of elimination: | Approximately 85 percent of cefoxitin is excreted unchanged by the kidneys over a 6-hour period, resulting in high urinary concentrations. Cefoxitin passes into pleural and joint fluids and is detectable in antibacterial concentrations in bile. |
Half Life: | The half-life after an intravenous dose is 41 to 59 minutes. |
Toxicity: | The acute intravenous LD50 in the adult female mouse and rabbit was about 8.0 g/kg and greater than 1.0 g/kg, respectively. The acute intraperitoneal LD50 in the adult rat was greater than 10.0 g/kg. |
Affected organisms: | Enteric bacteria and other eubacteria |
Drug interaction: |
|
---|